The Sports Medicine report provides a thoughtful overview of product specification, technology, product type, and production analysis considering major factors such as revenue, cost, and Gross margin. The report is sure to offer a brilliant solution to the challenges and issues faced by the sports medicine products industry. This market report includes in-depth study on various market segments and regions, emerging trends, key market drivers, challenges and opportunities in the market. An influential Sports Medicine Products market document also exhibits key developments in the Sports Medicine Products industry with respect to the current scenario and upcoming advancements.

Click here for the full report: https://www.worldwidemarketreports.com/buy/535804

The Sports Medicine report provides a thoughtful overview of product specification, technology, product type, and production analysis considering major factors such as revenue, cost, and Gross margin. The report is sure to offer a brilliant solution to the challenges and issues faced by the sports medicine products industry. This market report includes in-depth study on various market segments and regions, emerging trends, key market drivers, challenges and opportunities in the market. An influential Sports Medicine Products market document also exhibits key developments in the Sports Medicine Products industry with respect to the current scenario and upcoming advancements.

The major key vendors in this market are: Arthrex, Smith & Nephew, Depuy Synthes Companies, Stryker, Conmed, Zimmer Biomet, Breg, DJO Global, Mueller Sports Medicine, Wright Medical Group, Medtronic, RTI Surgical, Performance Health International Limited

By product type, the market is primarily split into: Body Reconstruction, Body Support & Recovery, Body Monitoring

By application, this report covers the following segments: Knee, Shoulder, Elbow

Regions Covered in Sports Medicine Products Market Report 2022:

✤ The Middle East and Africa (GCC countries and Egypt)
✤ North America (United States, Mexico and Canada)
✤ South America (Brazil etc.)
✤ Europe (Turkey, Germany, Russia UK, Italy, France etc.)
✤ Asia-Pacific (Vietnam, China, Malaysia, Japan, Philippines, Korea, Thailand, India, Indonesia and Australia)

By providing an absolute overview of the market, the Sports Medicine Products marketing report covers various aspects of market analysis, product definition, market segmentation, key developments, and existing vendor landscape. In this industry review report, the WMR industry patterns are detailed at a large scale, which helps clients and organizations sort out the trade center and conceivable future issues. The market report envelops the organization profiling of the central players on the prowl, cautiously dissecting their central abilities and drawing a serious scene for the market. The large-scale Sports Medicine Products report surely acts as a great motivator to seek new ventures and scale better.

Key point of the table of contents:

Market overview: This section includes research scope, market segments by type, sports medicine products market segments by application, key manufacturers covered, study objectives, and years considered.

Market Status and Outlook by Region: In this section, the report discusses gross margin, production, sales, revenue, market share, CAGR and market size by region.

Market Landscape and Manufacturer Profiles: In this section, the competition in the global sports medicine products market is analyzed, by price, revenue, sales and market share by company, market rates and latest trends, merger, expansion, acquisition and market shares of the most large companies. This section includes an analysis of leading players in the Sports Medicine Products market based on sales area, key products, gross margin, revenue, price, and production.

SWOT Analysis and Porter’s Five Forces Analysis are two of the standard and comprehensive methods used here for conducting market research and preparing specific reports on the Sports Medicine Products market. This report is very important for the planning of identified technologies such as creation, shipping of items, costing, inventory, purchasing and promotion. By discovering the best market openings, creative data can be presented to help you succeed. These robust reports provide the right answers to complex business issues and initiate easy and dynamic interactions. Hence, the Sports Medicine Products market research report helps to focus on more important aspects of the market.

Important report features:

✤ Detailed analysis of the sports medicine products market
✤ Fluctuating industry market dynamics
✤ Detailed market segmentation
✤ Historical, current and projected market size in terms of volume and value
✤ Recent industry trends and developments
✤ Competitive Landscape of Sports Medicine Products Market
✤ Strategies of key players and product offerings
✤ Potential and niche segments/regions showing promising growth
✤ A neutral perspective on the performance of the sports medicine products market.

Click here for the full report: https://www.worldwidemarketreports.com/buy/535804

✤ Report customization : Either way, please contact our team of research analysts, who will ensure that your requirements are met.

Contact us:

Global Market Reports,

Tel: USA +1-415-871-0703

UK +44-203-289-4040

Japan +81-50-5539-1737

E-mail: [email protected]

Website:https://www.worldwidemarketreports.com/

ATLANTA–(BUSINESS WIRE)–February 17, 2022–

Genexamaker of the world’s first clean medicines – made with the same effective active ingredients as conventional brands but without any of the artificial fillers – named Emily Culp as the company’s new Chief Marketing Officer (CMO). Culp will lead all branding, marketing and e-commerce strategy for Genexa, bringing with her more than two decades of marketing and e-commerce experience and a proven track record of accelerating growth by creating consumer-centric brands across channels and geographies, driving business transformation and introducing innovative new products.

This press release is multimedia. See the full version here: https://www.businesswire.com/news/home/20220217005233/en/

Emily Culp (Photo: Business Wire)

Culp joins Genexa at an exciting time of strong growth. In 2021, Genexa has expanded its retail footprint to 45,000 stores nationwide, including key retail partners such as Walmart, Target, Rite Aid, CVS, Whole Foods as well as online at Genexa.com and Amazon. The company also launched its first national broadcast marketing campaign and closed a highly successful and oversubscribed $60 million Series A that brought together some of the world’s most highly regarded consumer product investors. Hollywood’s top wellness advocates also took part in Series A, the biggest ever for a consumer pharmaceutical company. Famous investors passionate about the clean medicine movement include Gwyneth Paltrow, Chris Pratt, Katherine Schwarzenegger, Donald Glover, Lily Aldridge, Jennifer Meyer, Regina Hall, Sanaa Lathan, Don Cheadle, Bridgid Coulter, Lana Parrilla, Patrick Schwarzenegger, Tony Kanal, Zoey Deutch and Nikki Reed.

“We are very excited about the future of clean medicine, and Emily couldn’t be a better leader to help accelerate Genexa’s growth and embed our brand and our core mission – people first – in the hearts and minds of our consumers,” noted Co-founder and CEO of Genexa david johnson. “We are committed to giving everyone access to real choices and Emily’s passion and experience for mission-driven businesses will help shape our voice and brand with customers.”

“Genexa is doing something that I have never seen before in my decades of experience in over-the-counter drugs,” adds Genexa’s President Brian Perkins. “Inspired by putting people above all else, Genexa is driving innovation by challenging the way over-the-counter medicines are formulated, bringing safe, clean medicines to market in a way never before seen. possible. Emily’s passion and experience with mission-driven companies like ours will help shape our voice and brand with customers. »

Covering all traditional over-the-counter treatment categories, including colds and flu, pain relievers, digestion and allergies for infants, children and adults, Genexa’s medications have the same active ingredients as the leaders in category but, for the very first time, are made without any artificial inactive ingredients. including the plethora of artificial colors, talc, sorbitol, high fructose corn syrup, propylene glycol, titanium dioxide, and common allergens like gluten and lactose.

“I am honored and delighted to join Genexa. I deeply believe in the vision that Max and David have set forth – to finally give people the real choice to use medicines that are both effective and clean, medicines made by people who truly care about you and your family,” said Emily Culp, CMO of Genexa. “Years of development with leading doctors and experts means that there is finally effective medicine available without artificial colors, flavors and common allergens while retaining all the active ingredients you really need. To me, that means that better health options are finally available to everyone, and they’re made by a company that puts people first in every way.

Most recently, Emily was CEO of Cover FX, a clean beauty brand with a global presence across all channels. She led the transformation of the company by pivoting the business model to be more consumer-centric, global and DTC-focused and introducing new patent-pending products. Her leadership and vision have allowed Cover FX to maintain its position as a pioneer in the clean beauty category while adapting to changes within the industry.

Prior to joining Cover FX, Emily was Global CMO at Keds, where she was responsible for the strategic development and creative execution of Keds’ global marketing initiatives including retail development, omnichannel marketing, e-commerce, public relations, content development and product collaborations. Emily has also held global omnichannel marketing and retail transformation roles at Rebecca Minkoff, Clinique and Unilever. She was responsible for launching programs such as the “store of the future” at Rebecca Minkoff, negotiating the partnership between Unilever and Amazon, launching Clinique’s social media presence and expanding the DTC business. worldwide. She began her career in various positions with agencies such as Ogilvy & Mather, Arnold and Digitas.

Emily was recognized in Forbes as one of the most influential CMOs in the world, Business Intern on the list of the 50 most innovative CMOs in the world and on the Adweek 50 list. She frequently lectures at Columbia University and has spoken at many high-profile industry events, including boutique.org, NRF, Google Retail Summit and SXSW. Culp holds an MBA from Columbia University and a BA from Wake Forest University.

All of Genexa’s products are manufactured in accordance with relevant FDA guidelines and are project verified non-GMO and gluten-free. Many are also certified organic and vegan. As a Certified B-Corporation, Genexa is committed to using business as a force for good, adhering to rigorous standards of social and environmental performance, accountability and transparency.

For more information, visit Genexa.com.

ABOUT GENEXA

Founded by two fathers on a mission to revolutionize the medicine aisle, Genexa makes medicine with the same active ingredients people need, but without the artificial ingredients they don’t. We believe people deserve choices. That’s why our business is built on a commitment to putting people above everything else. All of our products are made to the highest medical standards with no artificial colors, common allergens or unnecessary inactive ingredients. It’s real medicine, made clean. Find out how we put people above all else, in everything we do, at Genexa.com.

Show source version on businesswire.com:https://www.businesswire.com/news/home/20220217005233/en/

CONTACT: SUPERJUICE

Alison Blue

ablue@superjuiceco.com

KEYWORD: UNITED STATES NORTH AMERICA GEORGIA

INDUSTRY KEYWORD: PHARMACEUTICALS ALTERNATIVE MEDICINE HEALTH CARE SPECIALTY ONLINE RETAILER RETAIL OTHER HEALTH

SOURCE: Genexa

Copyright BusinessWire 2022.

PUBLISHED: 02/17/2022 09:00 AM / DISK: 02/17/2022 09:02 AM

http://www.businesswire.com/news/home/20220217005233/en

The funding round is led by New Era Capital Partners and includes Peregrine Ventures, Robert Bosch Venture Capital, 20/20 HealthCare Partners and Pitango HealthTech

FRAMINGHAM, Mass., February 14, 2022 /PRNewswire/ — Variantexa technology-driven precision medicine company that provides advanced genomic testing for the rare genetic disease, reproductive health and precision oncology markets, today announced that it has been awarded $41.5M in financing. Series C-2 funding round, led by New Era Capital Partners and including Peregrine Ventures, Robert Bosch Venture Capital, 20/20 HealthCare Partners and Pitango HealthTech, will be used to fuel company growth and launch solutions newly developed in all markets, with a focus on precision oncology.

Variantyx is poised to capitalize on the rapidly growing global precision oncology market with access to North America and Europe, respectively the largest and fastest growing regions for oncology spending.

Variantyx’s proprietary whole genome sequencing and analysis platforms enable healthcare providers and their patients to better understand a person’s genetic makeup, leading to unparalleled diagnostic capabilities and treatment recommendations. improved personalized treatment. The company’s precision oncology solution will use multiple genomic technologies to analyze and identify unique genetic alterations in a patient’s tumor to help predict their response to various therapies, optimize management and provide insights on prognoses and clinical trials.

“The funding is a great show of confidence in the company,” said Haim Neerman, CEO of Variantyx. “This allows us to extend our diagnostic solutions to a wider range of customers so that medical care can become more personalized. Variantyx’s growth has been exponential, and we can’t wait to share the disruptive new products we have in the works.

This marks the continuation of the long-standing relationship between Variantyx and New Era Capital Partners. “Variantyx is changing the way precision medicine is practiced with the most advanced platform on the market, which can detect a range of genetic findings through whole genome analysis. It makes a huge difference in the diagnostics and treatment market,” says Gideon Argov, Managing Partner at New Era Capital Partners. “We are excited to help take the company to the next level, bringing personalized medicine to the mainstream.”

About Variantyx
Variantyx is a technology-driven precision medicine company providing disruptive solutions for the genetic disorders, reproductive health and precision oncology markets. The proprietary whole genome analysis platforms developed by Variantyx enable clinicians and patients to better understand a person’s genetic makeup, leading to unparalleled diagnostic capabilities and improved personalized treatment recommendations. For more information, please visit www.variantyx.com.

Contact:

DeeDee Rudenstein
drudenstein@propelsc.com

Show original content:https://www.prnewswire.com/news-releases/technology-driven-precision-medicine-company-variantyx-secures-41-5m-in-funding-301480542.html

SOURCEVariantex

New Latest Report on “Traditional Chinese Medicine Skin Care Products Market Size | Industry Segment by Applications (Beauty Salon, Household and Others), by Type (Daub Type Skin Care Products, Dietary Supplements and Acupuncture), Regional Outlook, Market Demand, Latest Trends, Traditional Medicine Products China for Skin Care Industry Growth and Revenue by Manufacturers, Company Profiles, Growth Forecast – 2025.” Analyzes current market size and upcoming growth of this industry over 5 years.

The Traditional Chinese Medicine Skin Care Products Market report is a research study that forecasts this business space to accumulate substantial revenue by the end of forecast period while registering growth rate modest over the estimated duration. The report also contains important details regarding market dynamics – for example, the myriad driving forces influencing the revenue scope of this industry. Additionally, the market dynamics detail the prevailing risks in this business field and the many growth opportunities that exist in this vertical.

Request a sample copy of this report @ https://www.getnewsalert.com/request-sample/17368

The Traditional Chinese Medicine Products for Skin Care Market report provides in-depth analysis and insights into developments impacting businesses and businesses at the global and regional levels.

Traditional Chinese Medicine for Skin Care Products Market Segment By Type considering Product, Revenue (Value), and Price Trends:

Market Segment by Applications Considering Consumption Growth Rate and Market Share:

Key Players profiled in this report include:

The report on the global Traditional Chinese Medicine Skin Care Products market mainly focuses on the following:

1- Presentation of traditional Chinese medicine products for skin care

2- Traditional Chinese Medicine Products by Region and Country for Skin Care Market Analysis

3- Traditional Chinese Medicine Products for Skin Care Market Technical Data and Manufacturing Plants Analysis

4- Production by Regions by Technology by Traditional Chinese Medicine Products for Skin Care Market Applications

5- Manufacturing process and cost structure

6- Productions Supply Sales Demand Market Status and Market Forecast

7- Key success factors and market share overview

8- Research methodology

The market across different regions is studied in the report which includes:

• North America (United States, Canada and Mexico)
• Europe (Germany, France, UK, Russia and Italy)
• Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
• South America (Brazil, Argentina, Colombia)
• Middle East and Africa (Saudi Arabia, United Arab Emirates, Egypt, Nigeria and South Africa)

The research objectives of this report are:

To analyze global Traditional Chinese Medicine Skin Care Products market status, future forecast, growth opportunity, key market and key players.

To present the Traditional Chinese Medicine Skin Care Products market development in United States, Europe and China.

Establish a strategic profile of the main players and analyze in depth their development plan and strategies.

To define, describe and forecast the market by product type, market and key regions.

The Traditional Chinese Medicine Skin Care Products Market study includes an in-depth assessment of this industry vertical focusing on the regional scope of this market along with a host of deliverables – like information regarding share market, revenue estimation, market concentration rate, market competition trends and sales volume. In addition, the Traditional Chinese Medicine Skin Care Products market report contains information about the sales channels adopted by various vendors to ensure that the best product marketing methodology is chosen.

Customization request on this report @ https://www.getnewsalert.com/request-for-customization/17368

New Jersey, United States,-The report attempts to offer an accurate and high-quality analysis of the global regenerative medicine products market, considering market forecasts, competitive intelligence, risks and technological advancements, and other significant topics. Its carefully crafted market intelligence enables market players to understand the most significant developments in the global Regenerative Medicine Products market that are impacting their business. Readers can become aware of crucial opportunities available in the global Regenerative Medicine Products market along with key factors driving and restraining the market growth. The research study also provides an in-depth geographical analysis of the global Regenerative Medicine Products market and sheds light on important applications and products that market players can focus on to achieve high growth.

Get | Download Sample Copy with TOC, Charts and List of Figures @ https://www.marketresearchintellect.com/download-sample/?rid=222856

You can thoroughly assess the strengths and weaknesses of your competitors with our competitive analysis. The report also provides access to a comprehensive analysis of production and shipment, from origin to end-user purchase. Plus, you’ll be updated on the latest industry developments to help you stay ahead of your competition. Our analysts are always on their toes to continuously track and analyze any changes or developments in the quality regenerative medicine products industry. The report is filled with statistical announcements, market figures related to annual revenue, volume, average and share, as well as global and regional market forecasts.

The report includes a detailed segmentation study of the global regenerative medicine products market, in which all the segments are analyzed in terms of market growth, share, growth rate, and other important factors. It also provides the attractiveness index of the segment, allowing players to inform about the profitable revenue pockets of the global regenerative medicine products market. A broad assessment of the segments provided in the report enables investments, strategy, and teams to focus on the right areas of the global regenerative medicine products market.

Major Players Covered by Regenerative Medicine Products Markets:

• Speed
• From Synthes
• Medtronic
• Zimmerbiomet
• stryker
• Mimedx Group
• Organogenesis
• Unique
• International cell dynamics
• Therapeutic Osiris
• Vcanbio
• Gamide cell
• Golden Meditech
• Cytori therapeutics
• Celgene
• Vericel Corporation
• Guanhao Biotech
• mesoblast
• Stem cell technologies
• Bellicum Pharmaceuticals

Regenerative Medicine Products Market Split By Type:

• Cell therapy
• Creation of fabrics
• Biomaterial
• Others

Regenerative Medicine Products Market Split By Application:

• Dermatology
• Cardiovascular
• CNS
• Orthopedic
• Others

The Regenerative Medicine Products Market report has been segregated into distinct categories such as product type, application, end-user, and region. Each segment is valued based on CAGR, share, and growth potential. In the regional analysis, the report highlights the prospective region, which is expected to generate opportunities in the global regenerative medicine products market in the coming years. This segmental analysis will surely prove to be a useful tool for readers, stakeholders, and market players to get a complete picture of the global Regenerative Medicine Products market and its growth potential in the coming years.

Get | Discount on the purchase of this report @ https://www.marketresearchintellect.com/ask-for-discount/?rid=222856